Release Date: February 27, 2025
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
Q: Could you elaborate on the assumptions behind your full-year 2025 guidance, particularly at the lower end of your target? Are you still expecting around EUR100 million contributions from new projects? A: The EUR100 million contribution from new projects is sensitive to macroeconomic conditions. While we expect growth in 2025, the extent will depend on macroeconomic developments. If conditions remain challenging, we might be at the lower end of the guidance. However, if the macroeconomic environment improves, we could reach the higher end of the range. Our focus remains on self-help initiatives to deliver superior performance compared to last year.
Q: Can you explain the strength in the downstream Coating Solutions business versus the weakness in upstream acrylics? Is this a supply issue? A: The weakness in upstream acrylics is not due to supply issues but rather low demand, particularly in Europe and the US. We are currently at a low point in the cycle for acrylics. However, we view this as a mid-term upside opportunity for the company, as normalized conditions could bring significant EBITDA improvements.
Q: Regarding the recurring cash flow target of EUR600 million for 2025, what should we expect in terms of nonrecurring items? A: The nonrecurring items in 2024 were significantly impacted by startup costs for the Singapore site and M&A transaction costs. Historically, nonrecurring items have been around EUR60 million. The EUR600 million target for recurring cash flow assumes normal IFRS cash flow generation, excluding lease costs.
Q: How do you view the competitive landscape in the adhesives market, especially with increased M&A activity in construction chemicals? A: The adhesives market has seen consolidation, but the competitive landscape remains stable for our product lines. We see opportunities in roofing and industrial adhesives, and we continue to participate in market consolidation. The stability of major players and consolidation of smaller ones present opportunities for growth.
Q: Can you provide more details on the impact of recent legislation on PFAS in France? A: The recent PFAS legislation in France concerns a ban on certain substances in textiles, cosmetics, and cookware. Arkema does not supply these markets, so there is no impact on our business.
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
This article first appeared on GuruFocus.免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。